Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PEG-hemoglobin data

The Piscataway, N.J., company was to present data today showing that its PEG-hemoglobin blood substitute can enhance the tumor-killing effect

Read the full 205 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE